Patent US4393466A successfully refreshed from Google Patents.
Patent US3969507A successfully refreshed from Google Patents.
US3969507A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of preventing and treating thrombosis
Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1974-11-11
•
Granted: 1976-07-13
•
Expires: 1994-11-11
Abstract
Abstract A method of preventing and treating thrombosis comprising administering a therapeutically effective amount of 5-(hydroxy-3-t-butylamino)propoxy-3,4-dihydrocarbostyril having the formula ##EQU1##
Inventors
- 👤 Hideaki Kohri
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 15:03
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/22; C07D215/227
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
35 words
A method for preventing blood platelet aggregation and minimizing blood platelet adhesion comprising applying in vitro to blood or in vivo to mammals afflicted with thrombosis an effective amount of 5-(hydroxy-3-t-butylamino)propoxy-3,4-dihydrocarbostyril having the formula ##EQU5##
Claim 2
Independent Claim
35 words
A method for preventing blood platelet aggregation and minimizing blood platelet adhesion comprising applying in vitro to blood or in vivo to mammals afflicted with thrombosis an effective amount of 5-(hydroxy-3-t-butylamino)propoxy-3,4-dihydrocarbostyril having the formula ##EQU5##
Claim 3
Dependent Claim
30 words
The method of claim 1 wherein the dihydrocarbostyril compound is present in the blood in an effective amount of from about 10 - 5 to about 10 - 11 M.
Claim 4
Dependent Claim
20 words
The method according to claim 2, wherein said effective amount ranges from 10 - 8 to 10 - 10 M.
Claim 5
Independent Claim
36 words
A method for treating thrombosis to prevent blood platelet aggregation and to minimize blood platelet adhesion in a subject afflicted therewith comprising administering a therapeutically effective amount of 5-(hydroxy-3-t-butylamino)propoxy-3,4-dihydrocarbostyril having the formula ##EQU6## to said subject.
Claim 6
Independent Claim
36 words
A method for treating thrombosis to prevent blood platelet aggregation and to minimize blood platelet adhesion in a subject afflicted therewith comprising administering a therapeutically effective amount of 5-(hydroxy-3-t-butylamino)propoxy-3,4-dihydrocarbostyril having the formula ##EQU6## to said subject.
Claim 7
Dependent Claim
30 words
The method of claim 4 wherein the dihydrocarbostyril compound is present in the blood in an effective amount of from about 10 - 5 to about 10 - 11 M.
Claim 8
Dependent Claim
20 words
The method according to claim 5, wherein said effective amount ranges from 10 - 8 to 10 - 10 M.
Claim 9
Dependent Claim
17 words
The method according to claim 4 wherein 5 to 10 mg per subject per day is administered.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-07-13 | 1980-01-12 | 1980-07-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-07-13 | 1984-01-12 | 1984-07-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-07-13 | 1988-01-12 | 1988-07-13 | $7700.00 | Window Closed / Lapsed |